Rituximab and febrile bone marrow aplasia Patient Reports February 11, 2012

Rituximab Side Effects Report #5968798-9
Rituximab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 12, 2008. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia. Rituximab dosage: 750 MG, QD. During the same period patient was treated with VINCRISTINE, METHOTREXATE, DEPOCYTE, CYCLOPHOSPHAMIDE, MEDROL, ADRIBLASTINE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5977887-4
Rituximab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 19, 2008. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia. Rituximab dosage: 750 MG, QD. During the same period patient was treated with VINCRISTINE, METHOTREXATE, DEPOCYTE, CYCLOPHOSPHAMIDE, MEDROL, ADRIBLASTINE, FOLIC ACID. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #6044784-8
Rituximab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 06, 2009. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia, skin necrosis. Rituximab dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISONE, CORTANCYL, NEXIUM, ZOPHREN, PRIMPERAN. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #6065610-7
Rituximab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 21, 2009. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia, skin necrosis. Rituximab dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISONE, CORTANCYL, NEXIUM, ZOPHREN, PRIMPERAN. Patient was hospitalized. Patient recovered.


Rituximab Side Effects Report #6086166-9
Rituximab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 06, 2009. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia. Rituximab dosage: 750 MG, QD. During the same period patient was treated with VINCRISTINE, METHOTREXATE, DEPOCYT, CYCLOPHOSPHAMIDE, MEDROL, ADRIBLASTINE, FOLIC ACID. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5655961-X
Rituximab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 25, 2008. Male patient was diagnosed with mantle cell lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia, hyperthermia. Rituximab dosage: 450 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5677820-9
Rituximab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 11, 2008. Male patient was diagnosed with mantle cell lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia, hyperthermia. Rituximab dosage: 450 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5761351-1
Rituximab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 27, 2008. Male patient was diagnosed with mantle cell lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: bacterial sepsis, febrile bone marrow aplasia, hyperthermia. Rituximab dosage: 450 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5773114-1
Rituximab side effect was reported by a Physician from UNITED KINGDOM on June 03, 2008. Female patient was diagnosed with mantle cell lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia. Rituximab dosage: 600 MG, UNK. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient was hospitalized. Patient recovered.


Rituximab Side Effects Report #5786604-2
Rituximab side effect was reported by a Physician from UNITED KINGDOM on June 11, 2008. Female patient was diagnosed with mantle cell lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia. Rituximab dosage: 600 MG, UNK. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5945084-4
Rituximab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 23, 2008. Male patient was diagnosed with mantle cell lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: acute sinusitis, bacterial sepsis, febrile bone marrow aplasia, hyperthermia, pseudomonas infection. Rituximab dosage: 450 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5821939-6
Rituximab side effect was reported by a Physician from UNITED KINGDOM on July 09, 2008. Female patient was diagnosed with diffuse large b-cell lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia. Rituximab dosage: 675 MG, QD. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, BLEOMYCIN SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5837784-1
Rituximab side effect was reported by a Physician from UNITED KINGDOM on July 25, 2008. Female patient was diagnosed with diffuse large b-cell lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia. Rituximab dosage: 675 MG, QD. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, BLEOMYCIN SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5886879-5
Rituximab side effect was reported by a Physician from UNITED KINGDOM on Sept 05, 2008. Female patient was diagnosed with diffuse large b-cell lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: condition aggravated, febrile bone marrow aplasia, folliculitis, injection site infection, rash . Rituximab dosage: 675 MG, QD. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, BLEOMYCIN SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.


Rituximab Side Effects Report #5906698-0
Rituximab side effect was reported by a Physician from UNITED KINGDOM on Sept 19, 2008. Female patient was diagnosed with diffuse large b-cell lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia, folliculitis, injection site infection, rash . Rituximab dosage: 675 MG, QD. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, BLEOMYCIN SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5912902-5
Rituximab side effect was reported by a Physician from UNITED KINGDOM on Sept 23, 2008. Male patient was diagnosed with diffuse large b-cell lymphoma, non-hodgkin's lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia. Rituximab dosage: 785 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, CORTANCYL. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5930218-8
Rituximab side effect was reported by a Physician from UNITED KINGDOM on Oct 10, 2008. Male patient was diagnosed with diffuse large b-cell lymphoma, non-hodgkin's lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia. Rituximab dosage: 785 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISONE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5936640-8
Rituximab side effect was reported by a Physician from UNITED KINGDOM on Oct 16, 2008. Male patient was diagnosed with diffuse large b-cell lymphoma, non-hodgkin's lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: escherichia sepsis, febrile bone marrow aplasia, mucosal inflammation, nephrotic syndrome. Rituximab dosage: 785 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISONE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5945698-1
Rituximab side effect was reported by a Physician from UNITED KINGDOM on Oct 23, 2008. Male patient was diagnosed with diffuse large b-cell lymphoma, non-hodgkin's lymphoma and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia, mucosal inflammation. Rituximab dosage: 785 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISONE. Patient was hospitalized. Patient recovered.


Rituximab Side Effects Report #4544877-8
Rituximab side effect was reported by a Physician from on Dec 22, 2004. Female patient, 69 years of age, weighting 134.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia, infection . Rituximab dosage: 500 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, BACTRIM DS, VALACYCLOVIR, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5007025-6
Rituximab side effect was reported by a Physician from FRANCE on May 04, 2006. Male patient, 69 years of age, weighting 220.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia. Rituximab dosage: 1050 MG, Q28D, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE, CALCIUM CARBONATE, VALSARTAN, PRAZOSINE, DOMPERIDON, PANTOPRAZOLE, FENOFIBRATE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5022437-2
Rituximab side effect was reported by a Physician from FRANCE on May 23, 2006. Male patient, 69 years of age, weighting 220.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia. Rituximab dosage: 1050 MG, Q28D, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE, CALCIUM CARBONATE, VALSARTAN, PRAZOSINE, DOMPERIDON, PANTOPRAZOLE, FENOFIBRATE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #4879549-3
Rituximab side effect was reported by a Physician from FRANCE on Dec 28, 2005. Female patient, 64 years of age, weighting 121.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia. Rituximab dosage: 785 MG, Q28D, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5548338-9
Rituximab side effect was reported by a Physician from UNITED KINGDOM on Dec 03, 2007. Female patient, weighting 143.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia. Rituximab dosage: 860 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.


Rituximab Side Effects Report #5548343-2
Rituximab side effect was reported by a Physician from UNITED KINGDOM on Dec 03, 2007. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with Rituximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia. Rituximab dosage: 860 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE, PANADO. Patient was hospitalized. Patient recovered.